Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
59
CPT Quote, Financials, Valuation and Earnings
Last price:
$108.56
Seasonality move
:
4.43%
Day range:
$107.56 - $109.35
52-week range:
$97.17 - $126.55
Dividend yield:
3.87%
P/E ratio:
30.73x
P/S ratio:
7.45x
P/B ratio:
2.57x
Volume:
1.4M
Avg. volume:
1.4M
1-year change:
-8.92%
Market cap:
$11.2B
Revenue:
$1.6B
EPS (TTM):
$3.53
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.4B | $1.5B | $1.6B | $1.6B | |
| Revenue Growth (YoY) | 9.26% | 23.88% | 8.06% | 0.59% | 2.02% | |
| Cost of Revenues | $868.6M | $1.1B | $1.2B | $1.2B | $1.2B | |
| Gross Profit | $285.5M | $323.4M | $385.8M | $372.7M | $367.2M | |
| Gross Profit Margin | 24.74% | 22.62% | 24.97% | 23.99% | 23.16% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $184.2M | $513.6M | $222.9M | $1.9M | -- | |
| Operating Expenses | $59.4M | $60.4M | $62.5M | $72.4M | $79.3M | |
| Operating Income | $226.1M | $263M | $323.3M | $300.4M | $287.9M | |
| Net Interest Expenses | $96M | $112.1M | $132M | $128.5M | $136.9M | |
| EBT. Incl. Unusual Items | $314.3M | $664.5M | $414.2M | $173.8M | $398.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9M | $3M | $3.7M | $2.9M | $4M | |
| Net Income to Company | $312.4M | $661.5M | $410.6M | $170.8M | $394.9M | |
| Minority Interest in Earnings | $8.5M | $7.9M | $7.2M | $7.5M | $10.4M | |
| Net Income to Common Excl Extra Items | $311.8M | $660.5M | $409.9M | $170.5M | $394.1M | |
| Basic EPS (Cont. Ops) | $2.97 | $6.07 | $3.71 | $1.50 | $3.54 | |
| Diluted EPS (Cont. Ops) | $2.96 | $6.03 | $3.70 | $1.50 | $3.54 | |
| Weighted Average Basic Share | $102M | $107.6M | $108.7M | $108.5M | $108.4M | |
| Weighted Average Diluted Share | $102.8M | $108.4M | $109.4M | $108.5M | $108.4M | |
| EBITDA | $646.8M | $840.1M | $898.1M | $882.4M | $898.9M | |
| EBIT | $226.1M | $263M | $323.3M | $300.4M | $287.9M | |
| Revenue (Reported) | $1.2B | $1.4B | $1.5B | $1.6B | $1.6B | |
| Operating Income (Reported) | $226.1M | $263M | $323.3M | $300.4M | $287.9M | |
| Operating Income (Adjusted) | $226.1M | $263M | $323.3M | $300.4M | $287.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $308.1M | $374.7M | $388.6M | $387.6M | $395.9M | |
| Revenue Growth (YoY) | 16.27% | 21.62% | 3.71% | -0.27% | 2.15% | |
| Cost of Revenues | $227.9M | $282.2M | $290.7M | $293.4M | $297.9M | |
| Gross Profit | $80.2M | $92.5M | $97.9M | $94.1M | $98M | |
| Gross Profit Margin | 26.02% | 24.68% | 25.19% | 24.29% | 24.75% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $177.5M | -- | $176.5M | -- | -- | |
| Operating Expenses | $14.9M | $15.9M | $15.7M | $18.7M | $19.8M | |
| Operating Income | $65.2M | $76.6M | $82.1M | $75.4M | $78.1M | |
| Net Interest Expenses | $24.3M | $28.4M | $33.6M | $32.3M | $33.8M | |
| EBT. Incl. Unusual Items | $218.5M | $48.2M | $225.1M | $43.2M | $159.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $601K | $753K | $897K | $572K | $1.4M | |
| Net Income to Company | $217.9M | $47.5M | $224.2M | $42.6M | $158M | |
| Minority Interest in Earnings | $5M | $1.8M | $1.8M | $1.9M | $1.9M | |
| Net Income to Common Excl Extra Items | $217.4M | $47.4M | $223.8M | $42.5M | $157.6M | |
| Basic EPS (Cont. Ops) | $2.03 | $0.42 | $2.04 | $0.37 | $1.44 | |
| Diluted EPS (Cont. Ops) | $2.03 | $0.42 | $2.03 | $0.37 | $1.43 | |
| Weighted Average Basic Share | $104.6M | $108.5M | $108.7M | $108.4M | $107.8M | |
| Weighted Average Diluted Share | $105.4M | $108.5M | $110.3M | $108.5M | $108.6M | |
| EBITDA | $181.7M | $223.9M | $227.1M | $220.9M | $228.3M | |
| EBIT | $65.2M | $76.6M | $82.1M | $75.4M | $78.1M | |
| Revenue (Reported) | $308.1M | $374.7M | $388.6M | $387.6M | $395.9M | |
| Operating Income (Reported) | $65.2M | $76.6M | $82.1M | $75.4M | $78.1M | |
| Operating Income (Adjusted) | $65.2M | $76.6M | $82.1M | $75.4M | $78.1M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.4B | $1.5B | $1.6B | $1.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $868.6M | $1.1B | $1.2B | $1.2B | $1.2B | |
| Gross Profit | $286.5M | $322.1M | $386.5M | $372.9M | $367.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $184.2M | $513.6M | $222.9M | $1.9M | -- | |
| Operating Expenses | $59.4M | $60.4M | $62.5M | $72.4M | $79.3M | |
| Operating Income | $227.1M | $261.7M | $324M | $300.5M | $288M | |
| Net Interest Expenses | $47.6M | $110.8M | $132.7M | $128.6M | $137M | |
| EBT. Incl. Unusual Items | $314.3M | $664.5M | $414.2M | $173.8M | $398.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9M | $3M | $3.7M | $2.9M | $4M | |
| Net Income to Company | $312.4M | $661.5M | $410.6M | $170.8M | $394.9M | |
| Minority Interest in Earnings | $8.5M | $7.9M | $7.2M | $7.5M | $10.4M | |
| Net Income to Common Excl Extra Items | $311.8M | $660.6M | $409.9M | $170.5M | $394.1M | |
| Basic EPS (Cont. Ops) | $2.93 | $6.05 | $3.71 | $1.50 | $3.54 | |
| Diluted EPS (Cont. Ops) | $2.93 | $6.00 | $3.69 | $1.50 | $3.53 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $647.8M | $838.8M | $898.8M | $882.5M | $899M | |
| EBIT | $227.1M | $261.7M | $324M | $300.5M | $288M | |
| Revenue (Reported) | $1.2B | $1.4B | $1.5B | $1.6B | $1.6B | |
| Operating Income (Reported) | $227.1M | $261.7M | $324M | $300.5M | $288M | |
| Operating Income (Adjusted) | $227.1M | $261.7M | $324M | $300.5M | $288M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.5B | $1.6B | $1.6B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.1B | $1.2B | $1.2B | $1.2B | -- | |
| Gross Profit | $322.1M | $386.5M | $372.9M | $367.3M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $513.6M | $222.9M | $1.9M | $47.3M | -- | |
| Operating Expenses | $60.4M | $62.5M | $72.4M | $79.3M | -- | |
| Operating Income | $261.7M | $324M | $300.5M | $288M | -- | |
| Net Interest Expenses | $110.8M | $132.7M | $128.6M | $137M | -- | |
| EBT. Incl. Unusual Items | $664.5M | $414.2M | $173.8M | $398.9M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3M | $3.7M | $2.9M | $4M | -- | |
| Net Income to Company | $661.5M | $410.6M | $170.8M | $394.9M | -- | |
| Minority Interest in Earnings | $7.9M | $7.2M | $7.5M | $10.4M | -- | |
| Net Income to Common Excl Extra Items | $660.6M | $409.9M | $170.5M | $394.1M | -- | |
| Basic EPS (Cont. Ops) | $6.05 | $3.71 | $1.50 | $3.54 | -- | |
| Diluted EPS (Cont. Ops) | $6.00 | $3.69 | $1.50 | $3.53 | -- | |
| Weighted Average Basic Share | $430.4M | $434.6M | $434M | $433.5M | -- | |
| Weighted Average Diluted Share | $432.9M | $437M | $434.1M | $435.2M | -- | |
| EBITDA | $838.8M | $898.8M | $882.5M | $899M | -- | |
| EBIT | $261.7M | $324M | $300.5M | $288M | -- | |
| Revenue (Reported) | $1.4B | $1.5B | $1.6B | $1.6B | -- | |
| Operating Income (Reported) | $261.7M | $324M | $300.5M | $288M | -- | |
| Operating Income (Adjusted) | $261.7M | $324M | $300.5M | $288M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $619M | $17.4M | $268M | $32.2M | $37.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $18.7M | $13.4M | $11.9M | $9M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $637.6M | $30.8M | $280M | $41.2M | $46.1M | |
| Property Plant And Equipment | $6.9M | $6M | $4.4M | $2.5M | $11M | |
| Long-Term Investments | $13.7M | -- | $11.6M | $21.9M | $24.9M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $234.4M | $229.4M | $244.2M | $234.8M | -- | |
| Total Assets | $8B | $9.3B | $9.4B | $8.9B | $9B | |
| Accounts Payable | $191.7M | $211.4M | $222.6M | $215.2M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $733.4M | $657.1M | $966.1M | $407.3M | $2.2B | |
| Long-Term Debt | $2.8B | $3.4B | $3.2B | $3.5B | $2.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.7B | $4.3B | $4.3B | $4.1B | $4.6B | |
| Common Stock | $1.1M | $1.2M | $1.2M | $1.2M | $1.2M | |
| Other Common Equity Adj | -$3.7M | -$1.8M | -$1.3M | $974K | -- | |
| Common Equity | $4.2B | $5B | $5B | $4.7B | $4.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $68.8M | $70.3M | $71M | $72M | $75.7M | |
| Total Equity | $4.3B | $5.1B | $5.1B | $4.7B | $4.4B | |
| Total Liabilities and Equity | $8B | $9.3B | $9.4B | $8.9B | $9B | |
| Cash and Short Terms | $619M | $17.4M | $268M | $32.2M | $37.2M | |
| Total Debt | $3.2B | $3.7B | $3.7B | $3.5B | $3.3B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $619M | $17.4M | $268M | $32.2M | $37.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $18.7M | $13.4M | $11.9M | $9M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $637.6M | $30.8M | $280M | $41.2M | $46.1M | |
| Property Plant And Equipment | $6.9M | $6M | -- | $2.5M | $11M | |
| Long-Term Investments | $13.7M | -- | -- | $21.9M | $24.9M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $234.4M | $229.4M | $244.2M | $234.8M | -- | |
| Total Assets | $8B | $9.3B | $9.4B | $8.9B | $9B | |
| Accounts Payable | $191.7M | $211.4M | $222.6M | $215.2M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $733.4M | $657.1M | $966.1M | $407.3M | $2.2B | |
| Long-Term Debt | $2.8B | $3.4B | $3.2B | $3.5B | $2.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.7B | $4.3B | $4.3B | $4.1B | $4.6B | |
| Common Stock | $1.1M | $1.2M | $1.2M | $1.2M | $1.2M | |
| Other Common Equity Adj | -$3.7M | -$1.8M | -$1.3M | $974K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $68.8M | $70.3M | $71M | $72M | $75.7M | |
| Total Equity | $4.3B | $5.1B | $5.1B | $4.7B | $4.4B | |
| Total Liabilities and Equity | $8B | $9.3B | $9.4B | $8.9B | $9B | |
| Cash and Short Terms | $619M | $17.4M | $268M | $32.2M | $37.2M | |
| Total Debt | $3.2B | $3.7B | $3.7B | $3.5B | $3.3B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $312.4M | $661.5M | $410.6M | $170.8M | $394.9M | |
| Depreciation & Amoritzation | $420.7M | $577M | $574.8M | $582M | $611M | |
| Stock-Based Compensation | $15.4M | $12.8M | $14.5M | $15.2M | $17M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $577.5M | $744.7M | $795M | $774.9M | $826.6M | |
| Capital Expenditures | $432.7M | $453.8M | $416.5M | $397.5M | $442.8M | |
| Cash Acquisitions | -- | $1.1B | -- | -- | $419.2M | |
| Cash From Investing | -$804.4M | -$1.5B | -$127.1M | -$285.2M | -$499.5M | |
| Dividends Paid (Ex Special Dividend) | $343M | $396.8M | $434.9M | $451M | $461M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.1B | $1.8B | $982M | -- | |
| Long-Term Debt Repaid | -- | -$1.1B | -$1.8B | -$1.2B | -- | |
| Repurchase of Common Stock | -- | -- | -- | $50M | $270.7M | |
| Other Financing Activities | $5.2M | -$2M | -$825K | $1.5M | -- | |
| Cash From Financing | $421.4M | $109.9M | -$417.2M | -$725.5M | -$322M | |
| Beginning Cash (CF) | $619M | $17.4M | $268M | $32.2M | $37.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $194.4M | -$601.5M | $250.6M | -$235.8M | $5M | |
| Ending Cash (CF) | $813.4M | -$584.1M | $518.7M | -$203.6M | $42.3M | |
| Levered Free Cash Flow | $144.7M | $290.9M | $378.4M | $377.3M | $383.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $217.9M | $47.5M | $224.2M | $42.6M | $158M | |
| Depreciation & Amoritzation | $116.5M | $147.3M | $145M | $145.5M | $150.2M | |
| Stock-Based Compensation | $3.2M | $3.1M | $3.6M | $4.4M | $4.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $141.4M | $168.2M | $192M | $152.4M | $196.8M | |
| Capital Expenditures | $148.4M | $107.4M | $117.3M | $87.1M | $131M | |
| Cash Acquisitions | -- | -- | -- | -- | $419.2M | |
| Cash From Investing | -$48.6M | -$108.1M | $113.6M | -$89.2M | -$21M | |
| Dividends Paid (Ex Special Dividend) | $87.9M | $103.6M | $110.4M | $113.5M | $115.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $418M | $641.2M | $328M | -- | |
| Long-Term Debt Repaid | -- | -$426M | -$590M | -$288M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $220.7M | |
| Other Financing Activities | $853K | $536K | -$1.3M | $202K | -- | |
| Cash From Financing | $92.6M | -$111.1M | -$60.5M | -$73.3M | -$175.9M | |
| Beginning Cash (CF) | $619M | $17.4M | $268M | $32.2M | $37.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $185.4M | -$51M | $245.1M | -$10.1M | -$67K | |
| Ending Cash (CF) | $804.4M | -$33.5M | $513.1M | $22.1M | $37.2M | |
| Levered Free Cash Flow | -$6.9M | $60.8M | $74.7M | $65.2M | $65.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $312.4M | $661.5M | $410.6M | $170.8M | $394.9M | |
| Depreciation & Amoritzation | $420.7M | $577M | $574.8M | $582M | $611M | |
| Stock-Based Compensation | $15.4M | $12.8M | $14.5M | $15.2M | $17M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $577.5M | $744.7M | $795M | $774.9M | $826.6M | |
| Capital Expenditures | $432.7M | $453.8M | $416.5M | $397.5M | $442.8M | |
| Cash Acquisitions | -- | $1.1B | -- | -- | $419.2M | |
| Cash From Investing | -$804.4M | -$1.5B | -$127.1M | -$285.2M | -$499.5M | |
| Dividends Paid (Ex Special Dividend) | $343M | $396.8M | $434.9M | $451M | $461M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.1B | $1.8B | $982M | -- | |
| Long-Term Debt Repaid | -- | -$1.1B | -$1.8B | -$1.2B | -- | |
| Repurchase of Common Stock | -- | -- | -- | $50M | $270.7M | |
| Other Financing Activities | $5.2M | -$2M | -$825K | $1.5M | -- | |
| Cash From Financing | $421.4M | $109.9M | -$417.2M | -$725.5M | -$322M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $194.4M | -$601.5M | $250.6M | -$235.8M | $5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $144.7M | $290.9M | $378.4M | $377.3M | $383.8M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $661.5M | $410.6M | $170.8M | $394.9M | -- | |
| Depreciation & Amoritzation | $577M | $574.8M | $582M | $611M | -- | |
| Stock-Based Compensation | $12.8M | $14.5M | $15.2M | $17M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $744.7M | $795M | $774.9M | $826.6M | -- | |
| Capital Expenditures | $453.8M | $416.5M | $397.5M | $442.8M | -- | |
| Cash Acquisitions | $1.1B | -- | -- | $419.2M | -- | |
| Cash From Investing | -$1.5B | -$127.1M | -$285.2M | -$499.5M | -- | |
| Dividends Paid (Ex Special Dividend) | $396.8M | $434.9M | $451M | $461M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.1B | $1.8B | $982M | $1.1B | -- | |
| Long-Term Debt Repaid | -$1.1B | -$1.8B | -$1.2B | -$766M | -- | |
| Repurchase of Common Stock | -- | -- | $50M | $270.7M | -- | |
| Other Financing Activities | -$2M | -$825K | $1.5M | -$417K | -- | |
| Cash From Financing | $109.9M | -$417.2M | -$725.5M | -$322M | -- | |
| Beginning Cash (CF) | $1.3B | $347.2M | $277.4M | $156.9M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$601.5M | $250.6M | -$235.8M | $5M | -- | |
| Ending Cash (CF) | $698.5M | $597.8M | $41.5M | $161.9M | -- | |
| Levered Free Cash Flow | $290.9M | $378.4M | $377.3M | $383.8M | -- | |
Get CPT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CPT
Sector
P/E ratio
30.73x
18.14x
PEG ratio
0.23x
0.05x
P/B ratio
2.57x
0.83x
Price / LTM sales
7.45x
3.17x
Growth Metrics
CPT
Sector
Revenue growth
2.15%
2.52%
Earnings growth
282.98%
--
Revenue (5-year growth)
8.46%
3.02%
Earnings forecast
$0.28
$0.13
Profitability
CPT
Sector
Profitability FY 2025
$367.2M
$149.1M
Return on invested capital
4.71%
1.98%
Return on assets
4.37%
1.78%
Return on equity
8.51%
3.5%
Earnings Date
Last Earnings Date
Feb
5
Next Earnings Date
Apr
30
Estimated Next Earnings Date
May
7
Balance Sheet
CPT
Sector
Total cash
$37.2M
$73.2M
Short term investments
--
$11.9M
Total assets
$9B
$3.2B
Long term debt
$3.3B
$340.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
